AirSculpt Technologies Inc (AIRS) Stock AnalysisAIRSAirSculpt Technologies Inc

AirSculpt Technologies, Inc. is engaged in providing body contouring treatment. The Company's treatment procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for healing with minimal bruising, tighter skin, and precise results. It offers a range of fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. It also offers AirSculpt +, which permanently removes fat and tightens the skin. Its treatment combines helium gas and radiofrequency energy to create a plasma equipped to correct sagging skin and restore a youthful, natural appearance. It operates in the Healthcare sector (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE industry).

Airsculpt Technologies Inc is currently not a strong buy due to its low price and negative performance indicators. The current price is $1.62, and the RSI is at 25.305, indicating oversold conditions. However, the stock has seen a significant decline of 83.30% over the past year, which raises concerns about its stability. The forward P/E ratio is currently at 0, reflecting uncertainty in future earnings. The main risk is the company's net income, which has been negative for multiple quarters, including a net loss of $1.1 million in Q2 2026.